Kotak Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.41 %Nav, as on 23-01-2025

  • Previous Nav

  • Net Change on 23-01-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 21.35 19.23 25.77 1.80 8,914.89
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 34.34 23.90 28.58 1.91 5,320.29
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 29.60 22.95 27.55 1.94 3,628.03
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 31.20 21.89 27.95 1.90 3,339.79
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 26.95 17.64 26.57 1.92 2,863.52

Fund Holdings as on 31-December-2024

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Cipla Ltd.

  • Divis Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • ORCHID PHARMA LIMITED

  • JB Chemicals & Pharmaceuticals Ltd.

  • Dr.Reddy's Laboratories Ltd.

  • Lupin Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Aurobindo Pharma Ltd.

  • JUBILANT PHARMOVA LIMITED

  • Apollo Hospitals Enterprise Ltd.

  • Alkem Laboratories Ltd.

  • INNOVA CAPTABS LTD

  • SAI LIFE SCIENCES LIMITED

  • Glenmark Pharmaceuticals Ltd

  • Ajanta Pharma Ltd.

  • Zydus Lifesciences Ltd.

  • ASTER DM HEALTHCARE LTD

  • Ami Organics Ltd

  • YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD

  • KRISHNA INSTITUTE OF MEDICAL

  • Krsnaa Diagnostics Ltd

  • Fortis Healthcare India Ltd

  • HIKAL LTD

  • Triparty Repo

  • Marksans Pharma Ltd

  • EMCURE PHARMACEUTICALS LIMITED

  • Alembic Pharmaceuticals Ltd.

  • Biocon Ltd.

  • Glaxosmithkline Pharma Ltd

  • Net Current Assets/(Liabilities)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

Fund Manager

  • Education:B. Tech, M.Tech, PGDM
  • Experience:17
  • Basic Details:Mr. Dhananjay Tikariha has overall 17 years of experience in Equity Research, Fund Management and Project Finance. Prior to joining KMAMC, he has also worked at IDFC Ltd.
  • Funds Managed:
  • Kotak Healthcare Fund
  • Kotak MNC Fund

  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹439.02 crore. Kotak Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Kotak Healthcare Fund ended up ₹0.19(1.41%)yesterday to ₹13.559.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455